Literature DB >> 12081593

Post-transplant renal function in the first year predicts long-term kidney transplant survival.

Sundaram Hariharan1, Maureen A McBride, Wida S Cherikh, Christine B Tolleris, Barbara A Bresnahan, Christopher P Johnson.   

Abstract

BACKGROUND: Improvements in long-term kidney graft survival have been recently noted. However, the reasons for this were unclear. This study examined post-transplant renal function within the first year as an independent variable influencing long-term survival.
METHODS: The influence of demographic characteristics (age, sex, race); transplant variables (cadaver versus living donor, cold ischemia time, HLA mismatching, delayed graft function and transplant year), and post-transplant variables (immunosuppressive agents for the prevention of acute rejection, clinical acute rejection and post-transplant renal function in the first year) on graft survival were analyzed for 105,742 adult renal transplants between 1988 and 1998. Renal function in the first year was expressed as serum creatinine at six months and one year and delta creatinine (change in serum creatinine between 6 months and 1 year). Graft half-life was used to measure long-term survival.
RESULTS: During this 11-year period, the one-year serum creatinine values for cadaver recipients steadily improved, from 1.82 +/- 0.82 mg/dL in 1988 to 1.67 +/- 0.82 mg/dL in 1998 (P < 0.001), as did the graft half-life. There was a progressive decline in graft half-life for each incremental increase of six month, one year and Delta creatinine for living and cadaver donor transplants as well for cadaver transplants with donor age > and < or =50 years. The Relative Hazard (RH) for graft failure was 1.63 (1.61, 1.65; P < 0.0001) with each increment of 1.0 mg/dL of serum creatinine at one year post-transplant and it increased to 2.26 (2.2, 2.31; P < 0.0001) when the Delta creatinine was 0.5 mg/dL. The RH reduction for graft failure was substantially lower for the years 1993, 1996, 1997 and 1998 when post-transplant renal function was not included in the model (P < 0.05). However, the RH reduction per year was not different when post-transplant creatinine was included in the model, 1.01 (0.94 to 1.05; P = 0.89).
CONCLUSION: In conclusion, one-year creatinine and Delta creatinine values predict long-term renal graft survival. Recent improvements in graft half-life are related to conservation of renal function within the first year post-transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081593     DOI: 10.1046/j.1523-1755.2002.00424.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  114 in total

1.  Periodontitis case definition affects the association with renal function in kidney transplant recipients.

Authors:  E Ioannidou; M Shaqman; J Burleson; A Dongari-Bagtzoglou
Journal:  Oral Dis       Date:  2010-10       Impact factor: 3.511

Review 2.  Disparities in kidney transplant outcomes: a review.

Authors:  Elisa J Gordon; Daniela P Ladner; Juan Carlos Caicedo; John Franklin
Journal:  Semin Nephrol       Date:  2010-01       Impact factor: 5.299

Review 3.  Cardiovascular risk factors following renal transplant.

Authors:  Jill Neale; Alice C Smith
Journal:  World J Transplant       Date:  2015-12-24

4.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

5.  CT-based renal volume and graft function after living-donor kidney transplantation: Is there a volume threshold to avoid?

Authors:  Jorge Dias; Jorge Malheiro; Manuela Almeida; Leonídio Dias; Miguel Silva-Ramos; La Salete Martins; Luís Xambre; António Castro-Henriques
Journal:  Int Urol Nephrol       Date:  2015-04-02       Impact factor: 2.370

6.  On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

Authors:  Yingyos Avihingsanon; Naili Ma; Martha Pavlakis; W James Chon; Marc E Uknis; Anthony P Monaco; Christiane Ferran; Isaac Stillman; Asher D Schachter; Christina Mottley; Xin Xiao Zheng; Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

7.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

8.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

9.  Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation.

Authors:  Stephanie R Earnshaw; Christopher N Graham; William D Irish; Reiko Sato; Mark A Schnitzler
Journal:  J Am Soc Nephrol       Date:  2008-06-18       Impact factor: 10.121

10.  Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.

Authors:  S Gourishankar; R Leduc; J Connett; J M Cecka; F Cosio; A Fieberg; R Gaston; P Halloran; L Hunsicker; B Kasiske; D Rush; J Grande; R Mannon; A Matas
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.